BRAF and colorectal carcinoma: In this cohort of PM-CRC cases, BRAF and RNF43 were 3–8 times more frequently mutated (27% and 16%, respectively) compared to previous reports from analyses of liver, 9% and 3%, and lung metastases, 6% and 2%, respectively [23, 37].